Autoimmune Diseases and HIV

Immune system diseases get up while acquired autoimmunity improvement to pathogenic autoimmunity. Hereditary components notwithstanding ecological reasons direct this turn of events. The global commercial center length of Autoimmune Disease Therapeutics was $109,833 million of every 2017 and is anticipated to reach $153,320 million with the guide of utilizing the surrender of 2025, with a CAGR of 4.2 18-2025.

    Related Conference of Autoimmune Diseases and HIV

    February 15-16, 2023

    11th World Summit on Immunology and Immunotherapy

    Zurich, Switzerland
    February 20-21, 2023

    Global Summit on SARS-CoV-2 virus

    Madrid, Spain
    May 24-25, 2023

    37th International Conference on Immunology

    Vienna, Austria

    Autoimmune Diseases and HIV Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in